Literature DB >> 12491334

The core structure of TMC-95A is a promising lead for reversible proteasome inhibition.

Markus Kaiser1, Michael Groll, Christian Renner, Robert Huber, Luis Moroder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12491334     DOI: 10.1002/1521-3773(20020301)41:5<780::aid-anie780>3.0.co;2-v

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  6 in total

1.  A concise, total synthesis of the TMC-95A/B proteasome inhibitors.

Authors:  Brian K Albrecht; Robert M Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-26       Impact factor: 11.205

2.  α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.

Authors:  Martina Bazzaro; Ravi K Anchoori; Mohana Krishna R Mudiam; Olga Issaenko; Srinivas Kumar; Balasubramanyam Karanam; Zhenhua Lin; Rachel Isaksson Vogel; Riccardo Gavioli; Federica Destro; Valeria Ferretti; Richard B S Roden; Saeed R Khan
Journal:  J Med Chem       Date:  2010-12-27       Impact factor: 7.446

3.  Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition.

Authors:  Jérôme Clerc; Michael Groll; Damir J Illich; André S Bachmann; Robert Huber; Barbara Schellenberg; Robert Dudler; Markus Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

4.  Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.

Authors:  David L Wilson; Isabel Meininger; Zack Strater; Stephanie Steiner; Frederick Tomlin; Julia Wu; Haya Jamali; Daniel Krappmann; Marion G Götz
Journal:  ACS Med Chem Lett       Date:  2016-01-15       Impact factor: 4.345

5.  Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.

Authors:  Grace E Hubbell; Jetze J Tepe
Journal:  RSC Chem Biol       Date:  2020-09-16

6.  Peptide and Peptide-Like Modulators of 20S Proteasome Enzymatic Activity in Cancer Cells.

Authors:  Carlos García-Echeverría
Journal:  Int J Pept Res Ther       Date:  2006-03-04       Impact factor: 1.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.